Form 4: Intuitive Surgical EVP Myriam Curet Executes Stock Options and Sells Shares Under 10b5-1 Trading Plan

Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Myriam Curet, an Executive Vice President and Chief Medical Officer at Intuitive Surgical Inc. (ISRG), engaged in transactions involving the company's common stock on April 23, 2024.
• Curet exercised non-qualified stock options to acquire 2,818 shares at a price of $177.9867 and 2,500 shares at a price of $182.8333.
• Simultaneously, Curet sold 2,818 shares and 2,500 shares at a weighted average price of $370.6582.
• These transactions were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1, set to expire on August 12, 2024.
• Following these transactions, Curet directly owns 298 shares of common stock and holds options for 5,075 and 5,000 shares respectively.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are part of a pre-planned trading strategy and do not necessarily reflect a change in the executive's outlook on the company.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating that the sales were planned in advance and not based on insider information.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. The use of a 10b5-1 trading plan is a standard practice to avoid insider trading concerns.

Comparison to Industry Standards

• Executive compensation packages in the medical device industry often include stock options as a significant component.
• The vesting schedule of the options (1/8th six months after grant and 1/48th monthly thereafter) is a fairly standard vesting schedule.
• The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including competitors like Medtronic and Stryker, to manage their stock holdings while avoiding insider trading accusations.

Stakeholder Impact

• The stock sale may have a minor downward impact on the stock price in the short term due to increased supply.
• However, the pre-planned nature of the sale mitigates concerns about insider information influencing the decision.

Key Dates